Holdings
Seven Fleet Capital Management LP
As of Sep 30, 2026, Seven Fleet Capital Management LP reported 77 positions worth US$460M. Largest: CG Oncology, Inc., Tango Therapeutics, Inc. and Revolution Medicines, Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| CG Oncology, Inc. | 1.89M | US$134M | no change | Sep 30, 2026 |
| Tango Therapeutics, Inc. | 2.23M | US$55.7M | −995K | Sep 30, 2026 |
| Revolution Medicines, Inc. | 265K | US$54.3M | +22,559 | Sep 30, 2026 |
| Liquidia Corporation | 596K | US$18M | +340K | Sep 30, 2026 |
| ArriVent BioPharma, Inc. | 451K | US$13.7M | +205K | Sep 30, 2026 |
| Enliven Therapeutics, Inc. | 262K | US$12M | −103K | Sep 30, 2026 |
| Avalo Therapeutics, Inc. | 773K | US$11.8M | +1,895 | Sep 30, 2026 |
| Xencor, Inc. | 445K | US$11.1M | +76,632 | Sep 30, 2026 |
| Roivant Sciences Ltd. | 290K | US$10.6M | +70,154 | Sep 30, 2026 |
| Abivax SA | 99,274 | US$9.83M | −12,060 | Sep 30, 2026 |